TC-G203
/ TCRCure
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 31, 2026
Preliminary Exploratory Clinical Study of TC-G203 for the Treatment of GPC3-Positive Recurrent/Metastatic Solid Tumors
(ChiCTR)
- P=N/A | N=14 | Not yet recruiting | Sponsor: Beijing Gaobo Hospital; Beijing Gaobo Hospital
New trial • Hepatocellular Cancer • Solid Tumor • GPC3
January 22, 2026
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Beijing GoBroad Hospital | Not yet recruiting ➔ Recruiting
Enrollment open • Hepatocellular Cancer • Oncology • Solid Tumor • GPC3
November 22, 2025
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Beijing GoBroad Hospital
New P1 trial • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1